BioOrbit
Latest round
- Seed
Last raised
- Mar 2026
Total raised
- $14M
Investors
- 6
About BioOrbit
BioOrbit, founded in 2023, is dedicated to producing pharmaceutical-grade crystals that improve the administration of biologic drugs.BioOrbit specializes in revolutionizing the administration of biologic medications by utilizing protein crystallization techniques developed for microgravity environments. The company’s core product is the production of pharmaceutical-grade crystals that enhance the stability and efficacy of biologic drugs, facilitating at-home injections for patients. This innovative approach addresses significant challenges in the healthcare sector, such as reducing the need for cold chain logistics and ensuring controlled release profiles for more effective treatment plans. The primary end users of BioOrbit's offerings include healthcare providers, pharmaceutical companies, and patients requiring biologic therapies, particularly in advanced markets like the United States and European Union, where the demand for enhanced drug delivery systems is growing rapidly.BioOrbit operates on a revenue model that includes partnerships with pharmaceutical companies and direct sales of its innovative drug delivery solutions. The company engages in contract agreements with clients to collaborate on the development and production of biologic medications using their advanced crystallization technology, which encompasses bulk supply agreements for their flagship products. BioOrbit plans to expand its market presence, focusing on the United States and European Union, where it will launch new products within the next few years.
Who invested in BioOrbit
6 investors across 1 round
See all investors in BioOrbit
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 2, 2026
Amount
$14M
Investors
Questions about BioOrbit
Who invested in BioOrbit?
BioOrbit has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioOrbit raised?
BioOrbit has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioOrbit last raise money?
BioOrbit's most recent round on record is a Seed, in Mar 2026.
What does BioOrbit do?
BioOrbit, founded in 2023, is dedicated to producing pharmaceutical-grade crystals that improve the administration of biologic drugs.
Where is BioOrbit headquartered?
BioOrbit is headquartered in London, UK.
Which VCs invest in companies like BioOrbit?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at BioOrbit's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like BioOrbit? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.